Volume 29, Number 6—June 2023
Dispatch
Enterovirus D68 Outbreak in Children, Finland, August–September 2022
Ville Peltola
, Riikka Österback, Matti Waris, Lauri Ivaska, Paula A. Tähtinen, Miia Laine, and Tytti Vuorinen
, Riikka Österback, Matti Waris, Lauri Ivaska, Paula A. Tähtinen, Miia Laine, and Tytti Vuorinen
Table
Baseline characteristics, diagnoses, and treatment of children hospitalized with EV-D68 respiratory illness in southwest Finland. August–September 2022*
| Variable | Children with EV-D68, N = 56 |
|---|---|
| Median age, years (IQR) |
4.23 (2.42–6.15) |
| Sex | |
| F | 19 (33.9) |
| M |
37 (66.1) |
| Underlying condition, any | 21 (37.5) |
| Asthma† | 15 (26.8) |
| Neurologic condition | 5 (8.9) |
| Premature birth, <37+0 gestational weeks | 4 (7.1) |
| Other condition‡ | 3 (5.4) |
| Other virus§ |
8 (14.3) |
| Diagnosis | |
| Wheezing illness¶ | 44 (78.6) |
| Pneumonia | 9 (16.1) |
| Upper respiratory tract infection |
3 (5.4) |
| Treatment | |
| Intensive care unit admission | 7 (12.5) |
| Respiratory support, any | 32 (57.1) |
| Supplemental oxygen | 22 (39.3) |
| High flow nasal oxygen | 10 (17.9) |
| Invasive ventilation | 0 (0) |
| Inhaled salbutamol | 53 (94.6) |
| Systemic corticosteroids | 42 (75.0) |
| Antibiotics |
20 (35.7) |
| Mean length of stay in the hospital, days (SD) | 2.75 (2.05) |
| Readmission# | 1 (1.8) |
*Values are no. (%) unless otherwise indicated. IQR, interquartile range; SD, standard deviation. †Confirmed or suspected asthma. ‡Cardiovascular condition, cystic fibrosis, or hypothyroidism. §Rhinovirus, n = 7; SARS-CoV-2, n = 3; and human bocavirus, n = 3. Including 3 patients who had 3 or 4 viruses. ¶Bronchiolitis, wheezing bronchitis, or exacerbation of asthma. #Within 14 days after discharge.
Page created: April 20, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.